Companies / Globus Medical Inc

Globus Medical Inc

NYSE: GMEDCIK 1237831AUDUBON, PAglobusmedical.com ↗

Financials · FY2025

Revenue$2.94B
Net income$537.87M
Total debt—
Cash$507.75M
Diluted EPS$3.92
Shares outstanding134.3M

Ownership

134.3M shares outstanding · as of Aug 4, 2026
0.42%Insiders
Ownership
Insiders0.42%560,978
10%+ / strategic4.38%5,885,560
Institutions85.71%115,077,791
Public float9.49%12,737,585

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 13

View all →
Insider% of sharesShares
Davidar David DDirector
0.38%510,175
Rhoads Ann DDirector
0.03%40,384
Norwalk Leslie VDirector
<0.01%10,419
Huller KellyEVP, GC, Corporate Secretary
0.00%0
Kline KyleSenior Vice President, CFO
0.00%0
DeFord John AFormerDirector
——
Douglas Robert AndrewDirector
——
Lemaitre DanFormerDirector
——
Paul David CExecutive Chairman · Director · 10% owner
——
Pfeil Keith WCEOPresident, CEO · Director
——

Institutional holders 575

View all →
HolderValue% of shares
Vanguard Group Inc$921.07M7.86%
BlackRock, Inc.$853.84M8.05%
Janus Henderson Group PLC$656.83M5.68%
Invesco Ltd.$339.32M2.89%
Bank of Montreal$294.52M2.51%
State Street Corporation$293.54M2.77%
JPMORGAN CHASE &amp; CO$270.55M2.31%
Sculptor Capital LP$263.48M2.28%
Madison Avenue International LP$229.17M1.95%
Citadel Advisors LLC$221.71M1.89%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 5, 2026Davidar David D
Director
SellClass A Common Stock$2.02M-25K
-4.67%
510,175
0.38% of shares
medium
Feb 25, 2026Huller Kelly
Executive
SellClass A Common Stock$1.89M-20K
-100.00%
0
0.00% of shares
medium
Feb 12, 2026Huller Kelly
Executive
SellClass A Common Stock$876.7K-10K
-100.00%
0
0.00% of shares
medium
Feb 25, 2026Huller Kelly
Executive
ExerciseClass A Common Stock$871.6K+20K
20,000
0.01% of shares
low
Jun 5, 2026Davidar David D
Director
ExerciseClass A Common Stock$656.8K+25K
+4.90%
535,175
0.40% of shares
low
Jun 4, 2026Rhoads Ann D
Director
ExerciseClass A Common Stock$656.8K+25K
+162.51%
40,384
0.03% of shares
low
Feb 12, 2026Huller Kelly
Executive
ExerciseClass A Common Stock$456.4K+10K
10,000
<0.01% of shares
low
Jan 8, 2026Kline Kyle
Executive
SellClass A Common Stock$363.4K-4K
-100.00%
0
0.00% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Capital ManagementPassive13G—5,885,560—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
GMED——379577208—